RxDoctor Payments Data

Jasleen Tiwana, MD

Interventional Cardiology · Anchorage, AKNPI 1922411685

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,218 of the $5,363 with a category attached, or 60.0%. 9 manufacturers reported payments, led by Medtronic at 58.6% of the total. Reporting peaked in 2024 at $3,581 and has fallen 69.6% since, to $1,089 in 2025.

$5,363in general payments, 2019–2025

Across 59 payments — averaging $90.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Boston Scientific$680
  • Asahi Intecc USA, Inc.$342
  • Abiomed$335
  • Verge Medical, Inc.$332
  • Teleflex LLC$272
  • plus $259 from 3 others

What the payments were for

  • Travel & lodging$3,21860%
  • Food & beverage$2,13840%
  • Education$60%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic21$3,144
Boston Scientific12$680
Asahi Intecc USA, Inc.10$342
Abiomed3$335
Verge Medical, Inc.2$332
Teleflex LLC3$272
Biotronik Inc.4$183
E.r. Squibb & Sons, L.L.C.2$41
Amgen2$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional cardiology providers in Alaskato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$244,812
Medicare patients
678
Services billed
2,962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$69,636
EntrestoSacubitril/Valsartan12$22,940
Metoprolol Succinate88$1,496
Atorvastatin Calcium69$986
ClopidogrelClopidogrel Bisulfate35$808
Isosorbide Mononitrate ErIsosorbide Mononitrate34$718
Losartan Potassium24$588
Rosuvastatin Calcium24$518
Carvedilol22$339
Lisinopril36$314
Spironolactone28$313
Ezetimibe13$267
Furosemide43$252
Warfarin Sodium12$90
Amlodipine Besylate23$78

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Anchorage

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →